Vaccines brighten their 2021 prospects: Wyndham Hotels and Wyndham Destinations

Article Excerpt

The coronavirus pandemic has forced the cancellation of most vacation plans. However, reopening of economy will spur strong demand for domestic travel—especially for lodgings that vacationers can reach by car. That already helped both Wyndham Destinations, and Wyndham Hotels and Resorts rebound from their March 2020 lows. Now, with COVID-19 vaccines being rolled out, the outlook for both these stocks keeps improving. We see both as buys. WYNDHAM HOTELS & RESORTS $56.47, is suitable for your new buying. The company (New York symbol WH; TSINetwork Rating: Extra Risk) (www.wyndhamhotels.com; Shares outstanding: 93.2 million; Market cap: $5.3 billion; Dividend yield: 0.6%) is the world’s largest hotel franchiser, with 804,300 rooms across 9,000 hotels in more than 90 countries. With the June 2020 payment, Wyndham Hotels cut its quarterly dividend by 75.0%, to $0.08 from $0.32. The new annual rate of $0.32 yields just 0.6%. Revenue in the quarter ended September 30, 2020, dropped 39.8%, to $337 million from $560 million a year earlier. Earnings fell 67.2%, to $0.36…